Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
88.29
+3.08 (3.61%)
At close: Oct 8, 2025, 4:00 PM EDT
87.50
-0.79 (-0.89%)
After-hours: Oct 8, 2025, 4:28 PM EDT
Arcellx Market Cap
Arcellx has a market cap or net worth of $4.90 billion as of October 8, 2025. Its market cap has increased by 5.17% in one year.
Market Cap
4.90B
Enterprise Value
4.41B
1-Year Change
5.17%
Ranking
Category
Stock Price
$88.29
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $4.90B, an increase of 873.16%. That is a compound annual growth rate of 85.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 4.73B | 13.95% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |